Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

Europe - FRA:QIA - NL0015002CX3 - Common Stock

41.17 EUR
-0.05 (-0.13%)
Last: 10/17/2025, 3:37:04 PM
Fundamental Rating

6

Taking everything into account, QIA scores 6 out of 10 in our fundamental rating. QIA was compared to 19 industry peers in the Life Sciences Tools & Services industry. QIA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QIA has a decent growth rate and is not valued too expensively. These ratings could make QIA a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

QIA had positive earnings in the past year.
In the past year QIA had a positive cash flow from operations.
In the past 5 years QIA has always been profitable.
Each year in the past 5 years QIA had a positive operating cash flow.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

The Return On Assets of QIA (6.41%) is better than 68.42% of its industry peers.
QIA's Return On Equity of 10.65% is fine compared to the rest of the industry. QIA outperforms 63.16% of its industry peers.
QIA has a better Return On Invested Capital (8.66%) than 68.42% of its industry peers.
QIA had an Average Return On Invested Capital over the past 3 years of 7.25%. This is in line with the industry average of 7.28%.
The 3 year average ROIC (7.25%) for QIA is below the current ROIC(8.66%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.41%
ROE 10.65%
ROIC 8.66%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

QIA has a better Profit Margin (18.30%) than 94.74% of its industry peers.
QIA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 26.86%, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of QIA has grown nicely.
Looking at the Gross Margin, with a value of 64.18%, QIA belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
Industry RankSector Rank
OM 26.86%
PM (TTM) 18.3%
GM 64.18%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

QIA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
QIA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for QIA has been reduced compared to 5 years ago.
Compared to 1 year ago, QIA has an improved debt to assets ratio.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 4.10 indicates that QIA is not in any danger for bankruptcy at the moment.
The Altman-Z score of QIA (4.10) is better than 84.21% of its industry peers.
The Debt to FCF ratio of QIA is 2.91, which is a good value as it means it would take QIA, 2.91 years of fcf income to pay off all of its debts.
QIA has a Debt to FCF ratio of 2.91. This is amongst the best in the industry. QIA outperforms 84.21% of its industry peers.
QIA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
QIA has a Debt to Equity ratio of 0.25. This is amongst the best in the industry. QIA outperforms 84.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.91
Altman-Z 4.1
ROIC/WACC1.17
WACC7.39%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

QIA has a Current Ratio of 1.61. This is a normal value and indicates that QIA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.61, QIA is in line with its industry, outperforming 52.63% of the companies in the same industry.
A Quick Ratio of 1.35 indicates that QIA should not have too much problems paying its short term obligations.
QIA has a better Quick ratio (1.35) than 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.35
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.20%, which is quite good.
The Earnings Per Share has been growing by 8.40% on average over the past years. This is quite good.
The Revenue has been growing slightly by 5.15% in the past year.
Measured over the past years, QIA shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%

3.2 Future

Based on estimates for the next years, QIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.78% on average per year.
QIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.82% yearly.
EPS Next Y8.61%
EPS Next 2Y8.32%
EPS Next 3Y8.49%
EPS Next 5Y8.78%
Revenue Next Year5.25%
Revenue Next 2Y5.5%
Revenue Next 3Y5.89%
Revenue Next 5Y7.82%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

QIA is valuated rather expensively with a Price/Earnings ratio of 20.48.
Based on the Price/Earnings ratio, QIA is valued a bit cheaper than 73.68% of the companies in the same industry.
When comparing the Price/Earnings ratio of QIA to the average of the S&P500 Index (27.29), we can say QIA is valued slightly cheaper.
A Price/Forward Earnings ratio of 18.40 indicates a rather expensive valuation of QIA.
68.42% of the companies in the same industry are more expensive than QIA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.85. QIA is around the same levels.
Industry RankSector Rank
PE 20.48
Fwd PE 18.4
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QIA is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 73.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.97
EV/EBITDA 14.5
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QIA does not grow enough to justify the current Price/Earnings ratio.
QIA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.38
PEG (5Y)2.44
EPS Next 2Y8.32%
EPS Next 3Y8.49%

2

5. Dividend

5.1 Amount

QIA has a yearly dividend return of 0.53%, which is pretty low.
QIA's Dividend Yield is a higher than the industry average which is at 0.69.
Compared to an average S&P500 Dividend Yield of 2.38, QIA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y8.32%
EPS Next 3Y8.49%
QIA.DE Yearly Income VS Free CF VS DividendQIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

QIAGEN N.V.

FRA:QIA (10/17/2025, 3:37:04 PM)

41.17

-0.05 (-0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners89.95%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.93B
Analysts74.17
Price Target44.77 (8.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.7%
Min EPS beat(2)-2.4%
Max EPS beat(2)7.8%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.51%
EPS beat(12)8
Avg EPS beat(12)3.69%
EPS beat(16)12
Avg EPS beat(16)5.44%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.43%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.85%
PT rev (1m)-0.99%
PT rev (3m)1.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.61%
EPS NY rev (1m)0.68%
EPS NY rev (3m)0.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 20.48
Fwd PE 18.4
P/S 5.1
P/FCF 20.97
P/OCF 15.41
P/B 2.97
P/tB 16.27
EV/EBITDA 14.5
EPS(TTM)2.01
EY4.88%
EPS(NY)2.24
Fwd EY5.44%
FCF(TTM)1.96
FCFY4.77%
OCF(TTM)2.67
OCFY6.49%
SpS8.08
BVpS13.88
TBVpS2.53
PEG (NY)2.38
PEG (5Y)2.44
Profitability
Industry RankSector Rank
ROA 6.41%
ROE 10.65%
ROCE 11.67%
ROIC 8.66%
ROICexc 10.87%
ROICexgc 46.44%
OM 26.86%
PM (TTM) 18.3%
GM 64.18%
FCFM 24.31%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.91
Debt/EBITDA 1.2
Cap/Depr 94.78%
Cap/Sales 8.78%
Interest Coverage 250
Cash Conversion 91.61%
Profit Quality 132.83%
Current Ratio 1.61
Quick Ratio 1.35
Altman-Z 4.1
F-Score8
WACC7.39%
ROIC/WACC1.17
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
EPS Next Y8.61%
EPS Next 2Y8.32%
EPS Next 3Y8.49%
EPS Next 5Y8.78%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
Revenue Next Year5.25%
Revenue Next 2Y5.5%
Revenue Next 3Y5.89%
Revenue Next 5Y7.82%
EBIT growth 1Y21.82%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.27%
EBIT Next 3Y22.23%
EBIT Next 5Y15.78%
FCF growth 1Y31.74%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y29.99%
OCF growth 3Y1.77%
OCF growth 5Y15.28%